Circulating Tumor Cells

Control of the course of disease.
Monitoring the effectiveness of cancer therapy. 

Chemosensitivity testing (ATP-TCA Test)

Individualized Chemotherapy based on ex vivo testing of living tumor cells.

Immunohistochemistry (IHC)

Standard and advanced determination of protein expression.

uPA/PAI-1

Risk assessment of node-negative breast cancer.
Need for chemotherapy in node-negative breast cancer. 

Mutation analysis

Gene expression profiling

Global and detailed CGE-Chip Analysis.
Endopredict-Test 

FISH Test

Reference method for determination of the HER2/neu status.